Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01504932 · ClinicalTrials.gov registry record · NA
Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors
A NA study of Stage III Squamous Cell Carcinoma of the Oropharynx and Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 1
- Study location
NCT01504932 is a NA study of Stage III Squamous Cell Carcinoma of the Oropharynx and Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 42 participants, below the 151-participant average among 4 other Stage III Squamous Cell Carcinoma of the Oropharynx trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01504932, a NA study of Stage III Squamous Cell Carcinoma of the Oropharynx and Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot clinical trial studies freeze-dried black raspberries (BRB) in preventing oral cancer recurrence in high at-risk Appalachian patients previously treated with surgery for oral cancer. Chemoprevention is the use of drugs natural products to keep cancer from developing, progressing, or recurring. Giving freeze-dried black raspberries may prevent oral cancer from forming or returning in oral cancer survivors.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Survey Administration
- OTHER pharmacological study
- DIETARY_SUPPLEMENT BRB Lozenge
Study Locations (1)
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2007-02-23 |
| Est. Completion | 2015-04-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01504932
The ClinicalTrials.gov registry entry for NCT01504932 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 151-participant average among 4 other Stage III Squamous Cell Carcinoma of the Oropharynx trials with a reported enrollment target (72% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stage III Squamous Cell Carcinoma of the Oropharynx appearing as the primary indexed condition, and to 4 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT01504932 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT01504932 about?
NCT01504932 is a clinical study titled "Freeze-Dried Black Raspberries in Preventing Oral Cancer Recurrence in High At-Risk Appalachian Patients Oral Cancer Survivors". This pilot clinical trial studies freeze-dried black raspberries (BRB) in preventing oral cancer recurrence in high at-risk Appalachian patients previously treated with surgery for oral cancer. Chemoprevention is the use of drugs natural products to keep cancer from developing, progressing, or recur...
What is the current status of trial NCT01504932?
This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2007-02-23. Estimated completion is 2015-04-22.
What conditions does trial NCT01504932 study?
This clinical trial studies the following conditions: Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Verrucous Carcinoma of the Oral Cavity, Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage I Squamous Cell Carcinoma of the Oropharynx.
What interventions are being tested in trial NCT01504932?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Survey Administration (OTHER), pharmacological study (OTHER), BRB Lozenge (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01504932?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01504932 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage III Squamous Cell Carcinoma of the Oropharynx
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Erlotinib, Docetaxel, and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer
COMPLETED · Phase 1
-
Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
COMPLETED · Phase 1
-
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
COMPLETED · Phase 2
Explore more on PlainTrial
Stage III Squamous Cell Carcinoma of the Oropharynx
All registered trials for this condition
Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity
All registered trials for this condition
Ohio
All trials with a study site in Ohio
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.